Skip Navigation
CNBC
Markets
  • Pre-Markets
  • U.S. Markets
  • Currencies
  • Prediction Markets
  • Cryptocurrency
  • Futures & Commodities
  • Bonds
  • Funds & ETFs
Business
  • Economy
  • Finance
  • Health & Science
  • Media
  • Real Estate
  • Energy
  • Climate
  • Transportation
  • Investigations
  • Industrials
  • Retail
  • Wealth
  • Sports
  • Life
  • Small Business
Investing
  • Personal Finance
  • Fintech
  • Financial Advisors
  • Options Action
  • ETF Street
  • Buffett Archive
  • Earnings
  • Trader Talk
Tech
  • Cybersecurity
  • AI
  • Enterprise
  • Internet
  • Media
  • Mobile
  • Social Media
  • CNBC Disruptor 50
  • Tech Guide
Politics & Policy
  • White House
  • Policy
  • Defense
  • Congress
  • Expanding Opportunity
Video
  • Latest Video
  • Full Episodes
  • Livestream
  • Live Audio
  • Live TV Schedule
  • CNBC Podcasts
  • CEO Interviews
  • CNBC Documentaries
  • Digital Originals
Watchlist
Investing Club
  • Trust Portfolio
  • Analysis
  • Trade Alerts
  • Meeting Videos
  • Homestretch
  • Jim's Columns
  • Education
  • Subscribe
Join IC
PRO
  • Pro News
  • Josh Brown
  • Mike Santoli
  • Calls of the Day
  • My Portfolio
  • Livestream
  • Full Episodes
  • Stock Screener
  • Market Forecast
  • Options Investing
  • Chart Investing
  • Subscribe
Join Pro
Livestream
  • Make It
  • select
  • USA
  • INTL
  • Livestream
  • Livestream
Watchlist
SIGN IN
Create free account
Markets
Business
Investing
Tech
Politics & Policy
Video
Watchlist
Investing Club
Join IC
PRO
Join Pro
Livestream

Top News & Analysis

Health and Science

  • Biotech and Pharma
  • Health Insurance
Stocks started the week with promise but ended in despair. Our take on the big reversal
Stocks started the week with promise but ended in despair. Our take on the big reversal
Alexa LoMonacoSat, Oct 31st 2026
Cramer’s week ahead: Expect more volatility as tech earnings, midterms loom
Cramer’s week ahead: Expect more volatility as tech earnings, midterms loom
Alexa LoMonacoFri, Oct 30th 2026
Gen Z is ditching bars for run clubs — and finding more than friends along the way
Gen Z is ditching bars for run clubs — and finding more than friends along the way
Alex HarringFri, Oct 30th 2026
A pharma major is touting an MS drug to ease patent-cliff fears
A pharma major is touting an MS drug to ease patent-cliff fears
Elsa OhlenFri, Oct 30th 2026
West Pharma: More than a GLP-1 play. The case for further upside
West Pharma: More than a GLP-1 play. The case for further upside
Harvey StoberThu, Oct 29th 2026
Cramer sees opportunity amid tech turmoil and predicts a holiday win for FedEx
Morning Meeting
Cramer sees opportunity amid tech turmoil and predicts a holiday win for FedEx
Thu, Oct 29th 2026
Merck tops estimates, hikes profit outlook on strength of injectable Keytruda
Health and Science
Merck tops estimates, hikes profit outlook on strength of injectable Keytruda
Thu, Oct 29th 2026
Eli Lilly blows past estimates, hikes sales outlook on resilient GLP-1 demand
Health and Science
Eli Lilly blows past estimates, hikes sales outlook on resilient GLP-1 demand
Thu, Oct 29th 2026

Trending Now

  • 1
    When someone won't stop talking, try 5 simple ways to get a word in, says expert
  • 2
    SpaceX loses bid to toss NAACP lawsuit over Memphis data center air pollution
  • 3
    Trump defamation suit against Murdoch, WSJ over Epstein letter dismissed with prejudice
  • 4
    Treasury Department announces new Series I bond rate of 5.51% for the next six months
  • 5
    Automakers like Rivian and Ford are ‘democratizing 3D printing’ to reduce costs and increase speed

More In Health and Science

GLP-1 coverage is shrinking for 2027. Here are weight-loss options for workers
The Bottom Line
GLP-1 coverage is shrinking for 2027. Here are weight-loss options for workers
Tue, Oct 27th 2026
Measles resurgence exposes deeper weaknesses in U.S. public health, experts say
Health and Science
Measles resurgence exposes deeper weaknesses in U.S. public health, experts say
Tue, Oct 27th 2026
Cramer: I asked tech insiders what to buy. They surprisingly said this drug stock
Analysis
Cramer: I asked tech insiders what to buy. They surprisingly said this drug stock
Mon, Oct 26th 2026
Health and Science
Amgen says drug combo slashes risk of death by 58% in patients with lung cancer
Sat, Oct 24th 2026
Health and Science
Doctors call Moderna, Merck's cancer vaccine data a major advancement
Fri, Oct 23rd 2026
Health and Science
Moderna shares plunge after cancer vaccine data leaks — despite positive results
Fri, Oct 23rd 2026
New bipartisan bill aims to speed up clinical trials for rare disease treatments
CNBC Cures
New bipartisan bill aims to speed up clinical trials for rare disease treatments
Thu, Oct 22nd 2026
Novo's CagriSema obesity drug shows 25% weight loss in women in analysis
Health and Science
Novo's CagriSema obesity drug shows 25% weight loss in women in analysis
Tue, Oct 20th 2026
Sickle cell gene therapies offer new hope, but access remains a major challenge
CNBC Cures
Sickle cell gene therapies offer new hope, but access remains a major challenge
Tue, Oct 20th 2026
Monthly Meeting
Here's our monthly update on our 32 stocks, including 2 more names to buy
Mon, Oct 19th 2026
Health and Science
Merck CEO tells CNBC he expects cancer vaccine will get faster to make over time
Thu, Oct 15th 2026
CNBC Changemakers
What Maven CEO Kate Ryder tells her kids every day amid AI education threat
Wed, Oct 14th 2026
Walmart to cover some GLP-1s, inhalers, insulin for employees at no cost
Health and Science
Walmart to cover some GLP-1s, inhalers, insulin for employees at no cost
Tue, Oct 13th 2026
UnitedHealth hikes profit outlook, tops estimates as insurer manages medical costs
Health and Science
UnitedHealth hikes profit outlook, tops estimates as insurer manages medical costs
Tue, Oct 13th 2026
Cramer: Starbucks tells me Chipotle takeover won't happen and that's good for the stock
Morning Meeting
Cramer: Starbucks tells me Chipotle takeover won't happen and that's good for the stock
Mon, Oct 12th 2026
Mad Money
Jim Cramer week ahead: Bank earnings, ASML and TSMC
Fri, Oct 9th 2026
CNBC Cures
For the final 10% of cystic fibrosis patients, the breakthrough still hasn't come
Fri, Oct 9th 2026
Politics & Policy
Trump doesn't think Russia plague incident is bioweapon, plans Putin call Wednesday
Wed, Oct 7th 2026
Trump set to talk to Russia's Putin 'very soon' about plague-related death in Siberia
Politics & Policy
Trump set to talk to Russia's Putin 'very soon' about plague-related death in Siberia
Wed, Oct 7th 2026
Jim Cramer says Grail can run higher as FDA decision on Galleri nears
Mad Money
Jim Cramer says Grail can run higher as FDA decision on Galleri nears
Tue, Oct 6th 2026
Russian lab worker's suspected plague death leaves experts puzzled
Health and Science
Russian lab worker's suspected plague death leaves experts puzzled
Tue, Oct 6th 2026
Politics & Policy
Trump offers U.S. help to Russia after plague death; WHO assesses the situation as low risk
Mon, Oct 5th 2026
Health and Science
AstraZeneca CEO says Summit Therapeutics drug could drive future cancer combos
Mon, Oct 5th 2026
Health and Science
Russian lab worker dies amid plague reports. Here's what we know
Mon, Oct 5th 2026
CNBC logo
  • Subscribe to CNBC PRO
  • Subscribe to Investing Club
  • Licensing & Reprints
  • CNBC Councils
  • Select Personal Finance
  • Join the CNBC Panel
  • Closed Captioning
  • Digital Products
  • News Releases
  • Internships
  • Corrections
  • About CNBC
  • Site Map
  • Podcasts
  • Careers
  • Help
  • Contact
  • News Tips

    Got a confidential news tip? We want to hear from you.

    Get In Touch
  • CNBC Newsletters

    Sign up for free newsletters and get more CNBC delivered to your inbox

    Sign Up Now

    Get this delivered to your inbox, and more info about our products and services.

  • Advertise With Us

    Please Contact Us
  • Ad Choices
  • Privacy Policy
  • California Consumer Privacy Act (CCPA) Opt-Out IconYour Privacy Choices
  • CA Notice
  • Terms of Service

© 2026 Versant Media, LLC. All Rights Reserved. A Versant Media Company.

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided byReuters logo